Aldulaijan Hajer A
Department of Periodontics, College of Dentistry, King Saud University, Riyadh 11451, Saudi Arabia.
Saudi Dent J. 2024 Sep;36(9):1160-1169. doi: 10.1016/j.sdentj.2024.07.017. Epub 2024 Aug 2.
In recent times, proton pump inhibitors (PPI) are frequently prescribed to manage acid reflux and to aid in completion of course of medication, which cause gastric irritation. Although this practice may minimize compliance to drug therapies and probably prevent development of drug resistance, the adverse effects of chronic PPI use have to be assessed. Inadvertent chronic use of PPIs has been found to inhibit normal gastrointestinal microbiome and even bone metabolism. The current study aimed to review available evidence based literature to understand the beneficial effects of PPIs weighed against their adversities with respect to periodontal and peri-implant health.
The search strategy was followed according to the PRISMA guidelines for systematic reviews. Proton pump inhibitors, periodontal disease, dental implant (DI) and bone osseointegration were used as key MESH terms to search and select the required articles for review. While primary inclusion criteria were original researches, published in English, between 2014 to till-date, case reports, reviews and editorial communications were excluded.
The overall search strategy resulted in 445 articles. Applying the inclusion and exclusion criteria 37 articles were selected. Scrutinizing the abstracts for relevance, 17 publications were finally selected for review. This included three in vivo animal studies evaluating DI osseointegration and 14 retrospective clinical studies (nine in patients with dental implants, four in patients with periodontitis and one evaluating bone quality using panoramic radiographs).
Findings from this systematic review revealed a plausible relationship between chronic PPI use and poor peri-implant bone health leading to early DI failure, and mandibular osteoporotic changes. On the contrary, use of PPI among patients with periodontitis, resulted in an improvement in periodontal health and reduction in periodontal disease severity.
近年来,质子泵抑制剂(PPI)常用于治疗胃酸反流并辅助完成药物疗程,但会引起胃部刺激。尽管这种做法可能会降低药物治疗的依从性,并可能预防耐药性的产生,但长期使用PPI的不良反应仍需评估。已发现不经意间长期使用PPI会抑制正常的胃肠道微生物群,甚至影响骨代谢。本研究旨在回顾现有循证文献,以了解PPI在牙周和种植体周围健康方面的利弊。
按照PRISMA系统评价指南进行检索策略。使用质子泵抑制剂、牙周疾病、牙种植体(DI)和骨骨结合作为关键医学主题词来检索和选择所需的综述文章。主要纳入标准为2014年至今发表的英文原创研究,排除病例报告、综述和编辑通信。
总体检索策略共获得445篇文章。应用纳入和排除标准后,选择了37篇文章。通过审查摘要的相关性,最终选择了17篇出版物进行综述。其中包括三项评估DI骨结合的体内动物研究和14项回顾性临床研究(9项针对牙种植体患者,4项针对牙周炎患者,1项使用全景X线片评估骨质量)。
该系统评价的结果表明,长期使用PPI与种植体周围骨健康不良导致早期DI失败以及下颌骨质疏松性改变之间存在合理的关联。相反,牙周炎患者使用PPI可改善牙周健康并降低牙周疾病严重程度。